Table 6.
S.·no | Pathway name | Entities found | Ratio | P value | FDRa | Reactions found | Ratio |
---|---|---|---|---|---|---|---|
1 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 4/21 | 0.001 | 2.57E-08 | 6.88E-06 | 4/18 | 0.001 |
2 | Potential therapeutics for SARS | 5/84 | 0.006 | 0.000000122 | 0.0000163 | 6/32 | 0.002 |
3 | SARS-CoV infections | 6/203 | 0.014 | 0.000000338 | 0.0000301 | 9/254 | 0.019 |
4 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 4/52 | 0.004 | 9.37e-07 | 6.28e-05 | 4/44 | 0.003 |
5 | Trafficking and processing of endosomal TLR | 3/16 | 0.001 | 1.75e-06 | 9.29e-05 | 2/7 | 5.21e-04 |
6 | Infectious disease | 9/1343 | 0.092 | 0.0000516 | 0.002 | 16/750 | 0.056 |
7 | VEGF ligand-receptor interactions | 2/8 | 0.000551 | 0.0000633 | 0.002 | 3/4 | 0.000298 |
8 | VEGF binds to VEGFR leading to receptor dimerization | 2/8 | 5.51e-04 | 6.33e-05 | 0.002 | 2/3 | 2.23e-04 |
9 | RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | 2/11 | 7.57e-04 | 1.19e-04 | 0.003 | 1/8 | 5.96e-04 |
10 | Assembly of collagen fibrils and other multimeric structures | 3/67 | 0.005 | 1.23e-04 | 0.003 | 1/26 | 0.002 |
11 | Toll-like receptor cascades | 4/188 | 0.013 | 0.000141 | 0.003 | 14/185 | 0.014 |
12 | Disease | 11/2360 | 0.163 | 0.000148 | 0.003 | 99/1591 | 0.119 |
13 | Generic transcription pathway | 9/1555 | 0.107 | 0.000163 | 0.003 | 17/824 | 0.061 |
14 | Interleukin-4 and interleukin-13 signaling | 4/211 | 0.015 | 2.19e-04 | 0.004 | 2/47 | 0.004 |
15 | Regulation of gene expression by hypoxia-inducible factor | 2/15 | 0.001 | 2.21e-04 | 0.004 | 1/7 | 5.21e-04 |
16 | RNA polymerase II transcription | 9/1694 | 0.117 | 0.000314 | 0.004 | 17/885 | 0.066 |
17 | ERBB2 activates PTK6 signaling | 2/18 | 0.001 | 0.000318 | 0.004 | 2/2 | 0.000149 |
18 | ERBB2 regulates cell motility | 2/19 | 0.001 | 0.000354 | 0.005 | 2/2 | 0.000149 |
19 | Collagen formation | 3/104 | 0.007 | 0.000444 | 0.006 | 1/77 | 0.006 |
20 | PI3K events in ERBB2 signaling | 2/22 | 0.002 | 0.000473 | 0.006 | 5/7 | 0.000521 |
21 | Gene expression (transcription) | 9/1855 | 0.128 | 0.000622 | 0.007 | 23/1000 | 0.074 |
22 | Signaling by VEGF | 3/137 | 0.009 | 0.000983 | 0.011 | 49/86 | 0.006 |
23 | Signaling by ERBB2 KD Mutants | 2/35 | 0.002 | 0.001 | 0.011 | 15/17 | 0.001 |
24 | MHC class II antigen presentation | 3/148 | 0.01 | 0.001 | 0.011 | 3/26 | 0.002 |
25 | Degradation of the extracellular matrix | 3/148 | 0.01 | 0.001 | 0.011 | 6/105 | 0.008 |
False discovery rate.